{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:26:09Z","timestamp":1787214369210,"version":"build-2736575974"},"reference-count":57,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmol Eye Dis"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>This review examines the potential of Wharton\u2019s jelly\u2013derived mesenchymal stem cells (WJ-MSCs) as regenerative therapies for corneal ectasia, with an emphasis on keratoconus. Current standards, including corneal cross-linking, intrastromal corneal ring segments, and keratoplasty, stabilize or reshape the cornea but do not restore native extracellular matrix (ECM) architecture or correct underlying cellular dysfunction. WJ-MSCs offer a scalable, ethically accessible cell source with high proliferative capacity, low immunogenicity, and robust paracrine activity. Preclinical studies suggest that WJ-MSCs may acquire corneal epithelial- and keratocyte-like characteristics under in vitro induction conditions and may promote epithelial healing, reduce inflammation and haze, and improve stromal organization and biomechanics, collectively supporting their potential role in corneal regeneration. Early clinical experiences with MSC-based therapies in ocular surface disease indicate favorable safety and preliminary evidence of efficacy, while a phase 1b clinical trial of locally delivered allogeneic bone marrow\u2013derived MSCs supports the feasibility and short-term safety of ocular MSC administration, providing indirect translational support for future WJ-MSC studies. Mechanistically, WJ-MSCs act via coordinated paracrine signaling and extracellular vesicles, immunomodulation (TGF-\u03b2, IL-10, IDO, HLA-G), anti-fibrotic effects, ECM remodeling, and potential neurotrophic support. Cell-free derivatives (secretome\/EVs) may replicate therapeutic benefits with simplified manufacturing and repeat dosing. Key challenges include optimizing dose, route, and timing; enhancing intrastromal persistence and potency (e.g., via biomaterials and preconditioning); and standardizing Good Manufacturing Practice (GMP) production. Rigorous, multicenter randomized trials with harmonized imaging, biomechanical, and patient-reported outcomes are needed to confirm durability and clinical benefit, including in combination strategies with cross-linking. The regulatory pathway also requires early engagement with relevant regulatory agencies, science-based chemistry, manufacturing, and controls (CMC), standardized product characterization, validated potency assays, ethical umbilical-cord sourcing, and appropriate preclinical toxicology before clinical implementation. With disciplined clinical development, WJ-MSC-based therapies, including cells or cell-free products, could evolve into disease-modifying options that complement existing care and, in selected cases, reduce reliance on keratoplasty.<\/jats:p>","DOI":"10.1177\/25158414261475131","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:34:27Z","timestamp":1787049267000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Wharton\u2019s jelly\u2013derived mesenchymal stem cells in keratoconus"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-9704","authenticated-orcid":false,"given":"Masoud","family":"Khorrami-Nejad","sequence":"first","affiliation":[{"name":"Tehran University of Medical Sciences"},{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawshan Qasim","family":"Jumah","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"},{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-8613","authenticated-orcid":false,"given":"Hossein","family":"Aghamollaei","sequence":"additional","affiliation":[{"name":"Semnan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-5645","authenticated-orcid":false,"given":"Foroozan","family":"Narooie-Noori","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"},{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesam","family":"Hashemian","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2503-3322","authenticated-orcid":false,"given":"Khosrow","family":"Jadidi","sequence":"additional","affiliation":[{"name":"Semnan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00565-3"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1212314"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15050626"},{"key":"e_1_3_4_5_2","first-page":"1097","article-title":"Long-Term Outcomes of Progressive Thickness Intrastromal Corneal Ring Segments for Keratoconic Eyes: A 4-Year Follow-Up","volume":"10","author":"Khorrami-Nejad M","year":"2025","unstructured":"Khorrami-Nejad M, Jadidi K, Almaliky Z, et al. Long-Term Outcomes of Progressive Thickness Intrastromal Corneal Ring Segments for Keratoconic Eyes: A 4-Year Follow-Up. Cornea 2025; 10: 1097.","journal-title":"Cornea"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003832"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2021.1878813"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.4776"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03826-7"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278455"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101600"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2024.03.015"},{"issue":"236","key":"e_1_3_4_13_2","first-page":"158","article-title":"New Methods in Cardiac Regenerative Medicine: The Use of Induced Pluripotent Stem Cells, Exosomes, and Cardiac Patch Technology","volume":"34","author":"Dayani A","year":"2024","unstructured":"Dayani A, Ghiasi M. New Methods in Cardiac Regenerative Medicine: The Use of Induced Pluripotent Stem Cells, Exosomes, and Cardiac Patch Technology. Journal of Mazandaran University of Medical Sciences 2024; 34(236): 158\u2013176.","journal-title":"Journal of Mazandaran University of Medical Sciences"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041102"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1211217"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1030549"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101011"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063078"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1626353"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-1028"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003585"},{"issue":"2","key":"e_1_3_4_22_2","first-page":"467","article-title":"Expression of matrix metalloproteinases and their inhibitors in corneal stromal fibroblasts and keratocytes from healthy and keratoconus corneas","volume":"263","author":"Berger T","year":"2025","unstructured":"Berger T, Flockerzi E, Berger M, et al. Expression of matrix metalloproteinases and their inhibitors in corneal stromal fibroblasts and keratocytes from healthy and keratoconus corneas. Graefe's Archive for Clinical and Experimental Ophthalmology 2025; 263(2): 467\u2013475. https:\/\/doi.org\/10.1007\/s00417-024-06601-y","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.06.023"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","unstructured":"Dua HS Darren S Al-Aqaba TM et al. Elsevier 2023 pp. 51\u201364. Pathophysiology of keratoconus. Keratoconus.","DOI":"10.1016\/B978-0-323-75978-6.00005-4"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.8.7"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011121"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091852"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.01.007"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1418"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14304"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0494-5"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002319"},{"issue":"3","key":"e_1_3_4_33_2","first-page":"180","article-title":"Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and their Conditioned Medium","volume":"11","author":"Ariesta Shinta Dewi P","year":"2022","unstructured":"Ariesta Shinta Dewi P, Sitompul R, Adiwinata Pawitan J, et al. Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and their Conditioned Medium. Int J Mol Cell Med 2022; 11(3): 180\u2013196. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.11.3.180","journal-title":"Int J Mol Cell Med"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2025.100799"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0051"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108451"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxaf048"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2025.05.009"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.15283\/ijsc18034"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2018-0120"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.4.22"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3287"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2012.05.009"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46120792"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051254"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00301-X"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03054-0"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.05.004"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781003371601"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.03.076"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2018.02.003"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.01.013"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.06.007"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050467"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122797"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051032"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00397-z"},{"key":"e_1_3_4_58_2","unstructured":"Grantee CCRMSCCR. Novel stem cell therapy repairs irreversible corneal damage in clinical trial 2025. [Available from. https:\/\/www.nei.nih.gov\/about\/news-and-events\/news\/novel-stem-cell-therapy-repairs-irreversible-corneal-damage-clinical-trial"}],"container-title":["Therapeutic Advances in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/25158414261475131","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/25158414261475131","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/25158414261475131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:16:23Z","timestamp":1787213783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/25158414261475131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["10.1177\/25158414261475131"],"URL":"https:\/\/doi.org\/10.1177\/25158414261475131","relation":{},"ISSN":["2515-8414","2515-8414"],"issn-type":[{"value":"2515-8414","type":"print"},{"value":"2515-8414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"25158414261475131"}}